Skip to main content
Top
Published in: BMC Urology 1/2020

Open Access 01-12-2020 | Magnetic Resonance Imaging | Case report

Small cell carcinoma of the bladder with coexisting prostate adenocarcinoma: two cases report and literature review

Authors: Yanxia Liu, Hongming Xu, Bin Wu, Shuguang Liu, Qiang Luo

Published in: BMC Urology | Issue 1/2020

Login to get access

Abstract

Background

Primary small cell carcinoma of the bladder (SCCB) is a rare disease of the genitourinary tract and reported limitedly. SCCB is very aggressive and always mixed with other histologic components, but coexistence of SCCB and prostate adenocarcinoma is extremely rare.

Cases presentation

Two aged males (72 and 58 years) were included in this study. Both of them presented with gross hematuria as initial symptom. Magnetic resonance imaging (MRI) demonstrated protruding lesions in the urinary bladder. Pathological examination after radical cystectomy and prostatectomy showed the concurrence of SCCB and prostate adenocarcinoma. One patient died of liver and lung metastasis 8 months after surgery, and the other patient was still alive after 19 months of follow-up.

Conclusion

In this paper, we reported two unusual cases of coexistence of SCCB and prostate adenocarcinoma, and reviewed relative literatures with respect to the epidemiology, clinical features, pathologic features, diagnosis, treatment and prognosis of SCCB.
Appendix
Available only for authorised users
Literature
1.
go back to reference Berniker AV, Abdulrahman AA, Teytelboym OM, Galindo LM, Mackey JE. Extrapulmonary small cell carcinoma: imaging features with radiologic-pathologic correlation. Radiographics. 2015;35(1):152–63.CrossRef Berniker AV, Abdulrahman AA, Teytelboym OM, Galindo LM, Mackey JE. Extrapulmonary small cell carcinoma: imaging features with radiologic-pathologic correlation. Radiographics. 2015;35(1):152–63.CrossRef
2.
go back to reference Salhab M, Migdady Y, Donahue M, Xiong Y, Dresser K, Walsh W, Chen BJ, Liebmann J. Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma: a single institution experience. J ImmunoTher Cancer. 2018;6(1):42.CrossRef Salhab M, Migdady Y, Donahue M, Xiong Y, Dresser K, Walsh W, Chen BJ, Liebmann J. Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma: a single institution experience. J ImmunoTher Cancer. 2018;6(1):42.CrossRef
3.
go back to reference Ghervan L, Zaharie A, Ene B, Elec FI. Small-cell carcinoma of the urinary bladder: where do we stand? Clujul Med. 2017;90(1):13–7.PubMedPubMedCentral Ghervan L, Zaharie A, Ene B, Elec FI. Small-cell carcinoma of the urinary bladder: where do we stand? Clujul Med. 2017;90(1):13–7.PubMedPubMedCentral
4.
go back to reference Erdem GU, Ozdemir NY, Demirci NS, Sahin S, Bozkaya Y, Zengin N. Small cell carcinoma of the urinary bladder: changing trends in the current literature. Curr Med Res Opin. 2016;32(6):1013–21.CrossRef Erdem GU, Ozdemir NY, Demirci NS, Sahin S, Bozkaya Y, Zengin N. Small cell carcinoma of the urinary bladder: changing trends in the current literature. Curr Med Res Opin. 2016;32(6):1013–21.CrossRef
5.
go back to reference Hatano K, Kawamura N, Kakuta Y, Fukuhara S, Takada T, Harai T, Yamaguchi S, Adachi S. Three cases of small cell carcinoma of the urinary bladder: a case report. Hinyokika Kiyo. 2008;54(4):297–300.PubMed Hatano K, Kawamura N, Kakuta Y, Fukuhara S, Takada T, Harai T, Yamaguchi S, Adachi S. Three cases of small cell carcinoma of the urinary bladder: a case report. Hinyokika Kiyo. 2008;54(4):297–300.PubMed
6.
go back to reference Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.CrossRef Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.CrossRef
7.
go back to reference Attard G, Parker C, Eeles RA, Schroder F, Tomlins SA, Tannock I, Drake CG, de Bono JS. Prostate cancer. Lancet. 2016;387(10013):70–82.CrossRef Attard G, Parker C, Eeles RA, Schroder F, Tomlins SA, Tannock I, Drake CG, de Bono JS. Prostate cancer. Lancet. 2016;387(10013):70–82.CrossRef
8.
go back to reference Pasquier D, Barney B, Sundar S, Poortmans P, Villa S, Nasrallah H, Boujelbene N, Ghadjar P, Lassen-Ramshad Y, Senkus E. Small cell carcinoma of the urinary bladder: a retrospective, multicenter rare Cancer network study of 107 patients. Int J Radiat Oncol. 2015;92(4):904–10.CrossRef Pasquier D, Barney B, Sundar S, Poortmans P, Villa S, Nasrallah H, Boujelbene N, Ghadjar P, Lassen-Ramshad Y, Senkus E. Small cell carcinoma of the urinary bladder: a retrospective, multicenter rare Cancer network study of 107 patients. Int J Radiat Oncol. 2015;92(4):904–10.CrossRef
9.
go back to reference Cerulli C, Busetto GM, Antonini G, Giovannone R, Di Placido M, Soda G, De Berardinis E, Gentile V. Primary metastatic neuroendocrine small cell bladder cancer: a case report and literature review. Urol Int. 2012;88(3):365–9.CrossRef Cerulli C, Busetto GM, Antonini G, Giovannone R, Di Placido M, Soda G, De Berardinis E, Gentile V. Primary metastatic neuroendocrine small cell bladder cancer: a case report and literature review. Urol Int. 2012;88(3):365–9.CrossRef
10.
go back to reference Wang Y, Li Q, Wang J, Tong M, Xing H, Xue Y, Pan H, Huang C, Li D. Small cell carcinoma of the bladder. the characteristics of molecular alterations, treatment, and follow-up. Med Oncol. 2019;36(12):98.CrossRef Wang Y, Li Q, Wang J, Tong M, Xing H, Xue Y, Pan H, Huang C, Li D. Small cell carcinoma of the bladder. the characteristics of molecular alterations, treatment, and follow-up. Med Oncol. 2019;36(12):98.CrossRef
11.
go back to reference Trias I, Algaba F, Condom E, Espanol I, Segui J, Orsola I, Villavicencio H, Garcia Del Muro X. Small cell carcinoma of the urinary bladder. Presentation of 23 cases and review of 134 published cases. Eur Urol. 2001;39(1):85–90.CrossRef Trias I, Algaba F, Condom E, Espanol I, Segui J, Orsola I, Villavicencio H, Garcia Del Muro X. Small cell carcinoma of the urinary bladder. Presentation of 23 cases and review of 134 published cases. Eur Urol. 2001;39(1):85–90.CrossRef
12.
go back to reference Yilmaz S, Ipekci T, Akin Y. An extremely rare cause of hematuria: Adamantionma like Neuroectodermal tumor of bladder. Kuwait Med J. 2016;48(4):343–5. Yilmaz S, Ipekci T, Akin Y. An extremely rare cause of hematuria: Adamantionma like Neuroectodermal tumor of bladder. Kuwait Med J. 2016;48(4):343–5.
13.
go back to reference Sharma A, Sharma S, Patnaik N, Pradhan D, Satapathy K, Pradhan MR, Mohanty SK. Cytomorphologic and Immunophenotypic profile of a cohort of small cell carcinoma of the urinary bladder. Acta Cytol. 2016;60(5):475–80.CrossRef Sharma A, Sharma S, Patnaik N, Pradhan D, Satapathy K, Pradhan MR, Mohanty SK. Cytomorphologic and Immunophenotypic profile of a cohort of small cell carcinoma of the urinary bladder. Acta Cytol. 2016;60(5):475–80.CrossRef
14.
go back to reference Epstein JI. Diagnosis and reporting of limited adenocarcinoma of the prostate on needle biopsy. Modern Pathol. 2004;17(3):307–15.CrossRef Epstein JI. Diagnosis and reporting of limited adenocarcinoma of the prostate on needle biopsy. Modern Pathol. 2004;17(3):307–15.CrossRef
15.
go back to reference Epstein JI. An update of the Gleason grading system. J Urol. 2010;183(2):433–40.CrossRef Epstein JI. An update of the Gleason grading system. J Urol. 2010;183(2):433–40.CrossRef
16.
go back to reference Koay EJ, Teh BS, Paulino AC, Butler EB. A surveillance, epidemiology, and end results analysis of small cell carcinoma of the bladder: epidemiology, prognostic variables, and treatment trends. Cancer. 2011;117(23):5325–33.CrossRef Koay EJ, Teh BS, Paulino AC, Butler EB. A surveillance, epidemiology, and end results analysis of small cell carcinoma of the bladder: epidemiology, prognostic variables, and treatment trends. Cancer. 2011;117(23):5325–33.CrossRef
17.
go back to reference Kouba E, Cheng L. Neuroendocrine tumors of the urinary bladder according to the 2016 World Health Organization classification: molecular and clinical characteristics. Endocr Pathol. 2016;27(3):188–99.CrossRef Kouba E, Cheng L. Neuroendocrine tumors of the urinary bladder according to the 2016 World Health Organization classification: molecular and clinical characteristics. Endocr Pathol. 2016;27(3):188–99.CrossRef
18.
go back to reference Siefker-Radtke AO, Dinney CP, Abrahams NA, Moran C, Shen Y, Pisters LL, Grossman HB, Swanson DA, Millikan RE. Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience. J Urol. 2004;172(2):481–4.CrossRef Siefker-Radtke AO, Dinney CP, Abrahams NA, Moran C, Shen Y, Pisters LL, Grossman HB, Swanson DA, Millikan RE. Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience. J Urol. 2004;172(2):481–4.CrossRef
19.
go back to reference Carranza OE, Castanon E, Abella LE, Zudaire ME, Castillo A, Arevalo E, Fusco JP, Zudaire JJ, Carias R, Cambeiro M. Clinical management of small-cell carcinoma of the urinary tract: a 10-year single-center's experience. Clin Genitourin Canc. 2013;11(2):168–74.CrossRef Carranza OE, Castanon E, Abella LE, Zudaire ME, Castillo A, Arevalo E, Fusco JP, Zudaire JJ, Carias R, Cambeiro M. Clinical management of small-cell carcinoma of the urinary tract: a 10-year single-center's experience. Clin Genitourin Canc. 2013;11(2):168–74.CrossRef
20.
go back to reference Ou WT, Liang QL, Huang X, Li ZY, Liu QL. Small cell carcinoma of the urinary bladder: a case report and review of the literature. Oncol Lett. 2015;9(1):488–90.CrossRef Ou WT, Liang QL, Huang X, Li ZY, Liu QL. Small cell carcinoma of the urinary bladder: a case report and review of the literature. Oncol Lett. 2015;9(1):488–90.CrossRef
21.
go back to reference Moretto P, Wood L, Emmenegger U, Blais N, Mukherjee SD, Winquist E, Belanger EC, Macrae R, Balogh A, Cagiannos I. Management of small cell carcinoma of the bladder: consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO). Can Urol Assoc. 2013;7(1–2):E44–56.CrossRef Moretto P, Wood L, Emmenegger U, Blais N, Mukherjee SD, Winquist E, Belanger EC, Macrae R, Balogh A, Cagiannos I. Management of small cell carcinoma of the bladder: consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO). Can Urol Assoc. 2013;7(1–2):E44–56.CrossRef
22.
go back to reference Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T, Zattoni F. EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol. 2014;65(2):467–79.CrossRef Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T, Zattoni F. EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol. 2014;65(2):467–79.CrossRef
Metadata
Title
Small cell carcinoma of the bladder with coexisting prostate adenocarcinoma: two cases report and literature review
Authors
Yanxia Liu
Hongming Xu
Bin Wu
Shuguang Liu
Qiang Luo
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Urology / Issue 1/2020
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-020-00705-3

Other articles of this Issue 1/2020

BMC Urology 1/2020 Go to the issue